Medicinal Psilocybin in Utah
UT H.B. 167
Mental Illness Psychotherapy Drug Task Force
Utah HB 167, which passed the Utah House by a vote of 68 to 1 and the Utah Senate by a vote of 23 to 1 and has been signed by the Governer in March, will create a dedicated task force to research use of psilocybin to treat depression, post-traumatic stress disorder, anxiety, addiction and existential distress.
Potential Benefits of Medicinal Psilocybin
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcor Praesent sapien massa, convallis a pellentesque nec, egestas non nisi.
Obsessive Compulsive Disorder
Studies have found the efficacy data provides sufficient scientific grounds to justify psilocybin as a treatment for OCD.
Source
Anxiety and Depression
Researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults.
Source
Addiction
Researchers showed longtime smokers who had failed many attempts to drop the habit did so after a carefully controlled and monitored use of psilocybin.
Source
What does HB 167 mean for Utah?
The bill wouldn’t legalize psilocybin which is designated as a Schedule I drug. The Bill would authorize a task force to weigh the potential benefits with the potential dangers of legalization or decriminalization.
The group would meet and provide recommendations on:
- specific types and symptoms of mental illness for which the psychotherapy drug could be used as a treatment option;
- appropriate administration and dosage;
- any license or credential requirement for individuals administering said drugs;
- training that could be helpful for administers of the drug;
- the frequency at which psychotherapy drug may be used;
- any procedures to obtain, store, and monitor the use of the drugs;
- safety requirements and procedures for data tracking, and more.
Psychotherapy Drug Task Force
The task force consists of experts in fields of psychiatry, psychology, pharmacology, neuroscience, mental health, trauma focused therapy, and addiction medicine. It also includes representatives from Utah Medical Association, a Utah hospital, and patient advocacy groups.
Supporting Medical Research
Medical Psilocybin Publications and Resources
Johns Hopkins Medicine
Psychedelics Research and Psilocybin Therapy
ACS
Psilocybin Therapeutic Research: The Present and Future Paradigm
The Mental Health Clinician
Clinical potential of psilocybin as a treatment for mental health conditions
How Can I Get Involved?
We are so glad you asked.
Join Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcor Praesent sapien massa, convallis a pellentesque nec, egestas non nisi.
Donate
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcor Praesent sapien massa, convallis a pellentesque nec, egestas non nisi.
Mankind’s History of Psychedelics
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur finibus sodales urna, vel ornare orci cursus sit amet. Vivamus condimentum risus faucibus felis aliquet ullamcorper. Nulla condimentum, odio sit amet ullamcorper pretium, purus orci faucibus tortor, non suscipit lectus lorem at dolor. Aliquam rhoncus malesuada tortor
